Status:
ACTIVE_NOT_RECRUITING
Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation
Lead Sponsor:
University of Miami
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Stem Cell Transplantation
Myelodysplastic Syndromes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to pilot test an Electronic Health Mindfulness-based Music Therapy Intervention (eMBMT) intervention to improve health-related quality of life (HRQoL) and reduce symptom burd...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- have a primary diagnosis of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or non Hodgkin's Lymphoma (NHL)
- have a treatment plan for an allogeneic hematopoietic stem cell transplant
- Speak English or Spanish
Exclusion
- history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months)
- severe cognitive impairment (per the short portable mental status questionnaire)
- hearing impairment
- active alcohol or substance dependence within the past six months
- participated in music therapy or mindfulness programs in the past six months
Key Trial Info
Start Date :
November 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05968963
Start Date
November 28 2023
End Date
December 1 2025
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Miami
Miami, Florida, United States, 33136